Evidence map›Paper›PMID 38749761›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Successful Treatment of Ultrasound-confirmed Synovitis in Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis with Corticosteroid Therapy.

Kenji Saito, Jumpei Temmoku, Yuya Sumichika, Shuhei Yoshida, Haruki Matsumoto, Yuya Fujita, Naoki Matsuoka, Tomoyuki Asano, Toru Yago, Shuzo Sato and 1 more

Abstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kenji SaitoDepartment of Rheumatology, Fukushima Medical University School of Medicine, Japan.
Jumpei TemmokuDepartment of Rheumatology, Fukushima Medical University School of Medicine, Japan.
Yuya SumichikaDepartment of Rheumatology, Fukushima Medical University School of Medicine, Japan.
Shuhei YoshidaDepartment of Rheumatology, Fukushima Medical University School of Medicine, Japan.
Haruki MatsumotoDepartment of Rheumatology, Fukushima Medical University School of Medicine, Japan.
Yuya FujitaDepartment of Rheumatology, Fukushima Medical University School of Medicine, Japan.
Naoki MatsuokaDepartment of Rheumatology, Fukushima Medical University School of Medicine, Japan.
Tomoyuki AsanoDepartment of Rheumatology, Fukushima Medical University School of Medicine, Japan.
Toru YagoDepartment of Rheumatology, Fukushima Medical University School of Medicine, Japan.
Shuzo SatoDepartment of Rheumatology, Fukushima Medical University School of Medicine, Japan.
Kiyoshi MigitaDepartment of Rheumatology, Fukushima Medical University School of Medicine, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive clinically amyopathic dermatomyositis (CADM) is a subtype of dermatomyositis without severe myositis but with characteristic cutaneous manifestations and severe interstitial lung disease. Joint symptoms can occur in patients with anti-MDA5 antibody-positive CADM. However, the treatment strategy and utility of ultrasound for treating joint symptoms remain unknown. We herein report an 85-year-old man with anti-MDA5 antibody-positive CADM who presented with ultrasound-confirmed synovitis that improved with medium-dose corticosteroid therapy.

Indexed as

AutoantibodiesDermatomyositisInterferon-Induced Helicase, IFIH1SynovitisUltrasonographyAdrenal Cortex HormonesAged, 80 and overHumansMaleTreatment OutcomeAdrenal Cortex HormonesAutoantibodiesInterferon-Induced Helicase, IFIH1anti-MDA5 antibodyCADMsynovitisultrasound

Identifiers

PMID38749761
PMCPMC11157329

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.